Our lead candidate is a multifaceted attack antibody for ovarian cancer. Our approach enables targeting primary cancer cells directly, alongside enabling the immune system's natural anti-cancer function, all with one therapeutic antibody.
Trade on Tradewind BioScience
Tradewind BioScience shares
No active listings yet.
Be the first to post →